Marshall Wace’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Marshall Wace's CLB Position: Q2 2026 in Review
Marshall Wace sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 117,744 shares — an estimated $1.98M sold.
Marshall Wace first reported a position in CLB in Q1 2016 and held it in 16 quarters. The position peaked at $25.7M in Q2 2016. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Marshall Wace reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
- Marshall Wace sold 117,744 Core Laboratories shares in Q2 2026, an estimated $1.98M.
- Marshall Wace first reported a position in Core Laboratories in Q1 2016 and held it in 16 quarters.
- Marshall Wace's Core Laboratories position peaked at $25.7M in Q2 2016.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.